Nusano

About Nusano

Nusano is a physics company addressing the undersupplied radioisotopes market for medical, industrial, and commercial applications. Founded in 2016, the company is set to begin commercial operations in 2025 from its new 170,000-square-foot facility in West Valley City, Utah. The business model centers on producing and supplying a wide range of high-purity, cGMP-grade radioisotopes to drugmakers, hospitals, clinics, and industrial partners. Nusano's revenue is generated through supply agreements and beam time reservations for its production platform.

The company was co-founded by Dr. Howard C. Lewin, a leader in nuclear cardiology, and Dr. Glenn B. Rosenthal, a nuclear physicist and former UCLA research physicist who invented the core ion source technology. Their combined expertise in medicine and physics underpins the company's approach. Nusano has secured significant funding, including a Series C round of over $115 million in October 2024, with investors like The Wasatch Group, S32, Verily, and the American Cancer Society's BrightEdge. This capital is aimed at commercializing its initial products, lutetium-177 (n.c.a. Lu-177) and actinium-225 (Ac-225), with production scheduled to start in Q1 and H2 2025, respectively.

Nusano's core offering is a proprietary production platform that represents a significant advancement in radioisotope manufacturing. The system combines a patented, high-current ion source with a linear accelerator, enabling the production of over 40 different radioisotopes, with the capability to produce up to 12 simultaneously. This technology accelerates heavy particles into one of 12 targets, creating isotopes with greater efficiency and volume than traditional methods. A key differentiator is its flexibility; the system can switch between producing different isotopes in minutes, a process that can take months with conventional reactors. This allows Nusano to serve a diverse client base, from healthcare institutions developing next-generation cancer therapies to companies in aerospace, clean energy, and industrial sectors requiring isotopes for non-destructive testing and long-lived power sources.